Quality Of Life in Patients With Malignant Biliary Obstruction
NCT00579865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124
Last updated 2010-01-14
Summary
You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life.
Conditions
- Gallbladder Cancer
- Liver Cancer
- Bile Duct Cancer
Interventions
- BEHAVIORAL
-
questionnaires
complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure.
- BEHAVIORAL
-
questionnaires
complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure. Patients who have undergone bypass or resection will complete an additional set of questionnaires at 9 and 14 weeks.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Piera Robson, RN, BSN · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
NCT00482586 ·Status: COMPLETED
-
Navigating the Clinical Trial Process for Hepatocellular Carcinoma
NCT05859945 ·Status: NOT_YET_RECRUITING
-
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522 ·Status: COMPLETED ·Phase: NA
-
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
NCT02592538 ·Status: COMPLETED ·Phase: NA
-
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT01004978 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
NCT02924376 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
NCT00510627 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
NCT01042041 ·Status: COMPLETED ·Phase: PHASE1
-
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
NCT02725073 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400 ·Status: RECRUITING
-
Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments
NCT05443217 ·Status: UNKNOWN
-
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814 ·Status: RECRUITING
-
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986 ·Status: RECRUITING
-
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
NCT06462742 ·Status: RECRUITING
-
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
NCT04143516 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
NCT02773459 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
NCT01425879 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT02507765 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
NCT03253536 ·Status: RECRUITING
-
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
NCT01730937 ·Status: COMPLETED ·Phase: PHASE3
-
Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome
NCT01494324 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
NCT07124546 ·Status: RECRUITING ·Phase: NA
-
Effects of Antiviral Therapy on Patients With HBV-related HCC
NCT05406089 ·Status: COMPLETED
-
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
NCT06909188 ·Status: RECRUITING
-
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
NCT00553683 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2